Figure 1
Management of Staphylococcus aureus bacteremia (SAB) in patients with cardiac implantable electronic devices (CIEDs). BCx: blood cultures; EOT: end of therapy; hr: hour; IV: intravenous; PET-CT: positron emission tomography-computed tomography; TEE: transesophageal echocardiography
1Duration may be extended to 6 weeks in presence of infectious complications requiring prolonged antibiotics such as osteomyelitis and endovascular infection (ie, septic venous thrombosis).
Figure 2
Management of non-S. aureus gram-positive cocci and gram-positive rod bacteremia in patients with cardiac implantable electronic devices. CoNS: coagulase-negative staphylococci; PET-CT: positron emission tomography-computed tomography; TEE: transesophageal echocardiography
1Staphylococcus lugdunensis, Enterococcus faecalis, streptococci except S. pneumoniae and S. pyogenes, Granulicatella spp., Abiotrophia spp., Gemella spp.
Figure 3
Management of gram-negative bacteremia in patients with cardiac implantable electronic devices. HACEK: Hemophilus spp., Aggregatibacter spp., Cardiobacterium spp., Eikenella spp., Kingella spp.; PET-CT: positron emission tomography-computed tomography; TEE: transesophageal echocardiography